This product is freeze dried. All water molecules have been removed.
Every lot is tried & tested in a relevant biological assay.
Alomone Labs Guangxitoxin-1E inhibits KV2.1 channel currents expressed in Xenopus oocytes.Currents were elicited by application of voltage ramp from a holding potential of -80 mV to 60 mV in 100 msec, delivered every 10 seconds. A. Time course of channel activity (current amplitude at +40 mV), before (black) and during (green) application of 100 nM Guangxitoxin-1E (#STG-200). B. Top, illustration of the voltage ramp protocol. Bottom, example of superimposed current traces before (black) and during (green) application of 100 nM Guangxitoxin-1E, taken from the experiment in A.
Guangxitoxin-1E is a 36 amino acid peptidyl toxin isolated from the Chilobrachys jingzhao (Chinese earth tiger) tarantula venom and belongs to the huwentoxin-1 family. Guangxitoxin-1E is a gating modifier of KV2.1 (KCNB1, IC50 of 1 nM), KV2.2 (KCNB2, IC50 of 3 nM) and KV4.3 (KCND3, IC50 of 50 nM) channels1. In pancreatic β cells, it enhances glucose-stimulated insulin secretion by broadening the cell action potential and enhancing calcium oscillations1,2. The physiological modulation of KV2.1 channels during glucose-induced insulin secretion is MgATP-mediated3,4. No significant effect was found on KV1.2 (KCNA2), KV1.3 (KCNA3), KV1.5 (KCNA5), KV3.2 (KCNC2), CaV1.2 (CACNA1C), CaV2.2 (CACNA1B), NaV1.5 (SCN5A), NaV1.7 (SCN9A) or NaV1.8 (SCN10A) channels1,2.
Alomone Labs Guangxitoxin-1E blocks KV2 channels in mouse acute cortical brain slices.KV2 mediated currents in mouse pyramidal cells are blocked by 100 nM application of Guangxitoxin-1E (#STG-200) (grey trace). Voltage protocol is shown below.Adapted from Bishop, H.I. et al. (2015) J. Neurosci. 35, 14922. with permission of the Society for Neuroscience.
Guangxitoxin-1E (#STG-200) is a highly pure, synthetic, and biologically active peptide toxin.
Gayet-Primo, J. et al. (2018) J. Neurosci. 38, 3414.
Smith, P. et al. (2018) Sci. Rep. 8, 7664.
- Fletcher, E.V. et al. (2017) Nat. Neurosci. 20, 905.
- Honigsperger, C. et al. (2017) J. Physiol. 595, 739.
- Frazzini, V. et al. (2016) Cell Death Dis. 7, 22100.
- Pathak, D. et al. (2016) J. Neurophysiol. 115, 2317.
- Stas, J.I. et al. (2016) Sci. Rep. 6, 35080.
- Bishop, H.I. et al. (2015) J. Neurosci. 35, 14922.
Blockers/Antagonists: peptides/peptide toxinsBlockers/Antagonists: small molecules